By the time the disease progresses to fasting hyperglycemia, progressive fall in the second-phase insulin secretion is also documented.[4–6] Thus, even at the time of diagnosis, type-2 DM is characterized by a dual defect, namely, insulin resistance and deficient insulin secretion. This evidence concerns the gene INS and Insulin resistance.